Alector (ALEC) Current Assets (2018 - 2026)
Alector's (ALEC) quarterly Current Assets came in at $180.1 million in Q2 2026, down 43.58% year-over-year from $319.2 million in Q2 2025, and down 16.27% quarter-over-quarter from $215.1 million in Q1 2026.
Analysis
Alector (ALEC) Current Assets (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Current Assets for 9 consecutive years, with $180.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Assets fell 43.58% year-over-year to $180.1 million in Q2 2026; TTM through Jun 2026 was $180.1 million, a 43.58% decrease from a year earlier, with the FY2025 full-year figure at $266.5 million, down 37.28% from the prior year.
- Current Assets was $180.1 million for Q2 2026 at Alector, down from $215.1 million in the prior quarter.
- Over five years, Current Assets peaked at $890.9 million in Q1 2022 and troughed at $180.1 million in Q2 2026.
- A 5-year average of $520.9 million and a median of $542.8 million in 2023 frame the typical range for Current Assets.
- Across the five-year window, Current Assets surged 151.12% in 2022 and slumped 43.58% in 2026, its largest moves.
- Over 5 years, Current Assets stood at $726.4 million in 2022, then declined by 22.11% to $565.8 million in 2023, then decreased by 24.92% to $424.8 million in 2024, then sank by 37.28% to $266.5 million in 2025, then plunged by 32.41% to $180.1 million in 2026.
- The last three Current Assets figures came in at $180.1 million (Q2 2026), $215.1 million (Q1 2026), and $266.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 34.96 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 13.95 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 12.54 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 18.45 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 8.07 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 5.82 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 7.31 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 180.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 180.09 Mn |
| Mar 31, 2026 | 215.08 Mn |
| Dec 31, 2025 | 266.45 Mn |
| Sep 30, 2025 | 300.39 Mn |
| Jun 30, 2025 | 319.18 Mn |
| Mar 31, 2025 | 366.65 Mn |
| Dec 31, 2024 | 424.82 Mn |
| Sep 30, 2024 | 469.36 Mn |
| Jun 30, 2024 | 519.70 Mn |
| Mar 31, 2024 | 581.39 Mn |
| Dec 31, 2023 | 565.81 Mn |
| Sep 30, 2023 | 613.15 Mn |
| Jun 30, 2023 | 647.99 Mn |
| Mar 31, 2023 | 686.00 Mn |
| Dec 31, 2022 | 726.44 Mn |
| Sep 30, 2022 | 774.96 Mn |
| Jun 30, 2022 | 827.02 Mn |
| Mar 31, 2022 | 890.93 Mn |
| Dec 31, 2021 | 749.71 Mn |
| Sep 30, 2021 | 788.02 Mn |